You are viewing the site in preview mode

Skip to main content

Advertisement

Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Oral fosfomycin for treatment of urinary tract infection: a retrospective cohort study

Fig. 1

Number of fosfomycin treatment episodes by month in a cohort of adults treated for UTI in a UK teaching hospital. Each data point represents the number of unique fosfomycin prescriptions (irrespective of total dose) issued each month, from the time fosfomycin was first introduced to our formulary (March 2013) over 27 months to the end of the study period (May 2015). The solid line represents the trend computed by linear regression (slope = 0.46, 95 % CI 0.31-0.62, R2 = 0.6, p < 0.0001); the dashed lines indicate 95 % confidence intervals around the regression line

Back to article page